TITLE

Determinants of antithrombin consumption in cardiac operations requiring cardiopulmonary bypass

AUTHOR(S)
Ranucci, Marco; Ditta, Antonio; Boncilli, Alessandra; Cotza, Mauro; Carboni, Giovanni; Brozzi, Simonetta; Bonifazi, Claudio; Tiezzi, Alessandra
PUB. DATE
January 2004
SOURCE
Perfusion;Jan2004, Vol. 19 Issue 1, p47
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Antithrombin (AT) is a natural anticoagulant that is consumed during cardiac operations with cardiopulmonary bypass (CPB). This study is an observational trial aimed at identifying the factors determining the magnitude of the AT consumption during cardiac operations. Two hundred and fifty consecutive adult patients undergoing cardiac operations with CPB were admitted to the study. Preoperative and intraoperative variables were tested with respect to their role in determining ATactivity at the end of the operation. At a univariate analysis, eight predictors of AT activity at the end of the operation have been identified: preoperative AT activity; age; diabetes on medication; preoperative haematocrit value; preoperative dialysis; combined operation; CPB duration; lowest temperature on CPB. A multivariate predictive model was created, and five factors remained as independent predictors of AT activity at the end of the operation: preoperative AT activity (p = 0.001); age (p = 0.015); combined operation (p = 0.014); diabetes (p = 0.013) and CPB duration (p = 0.001). On this basis, predictive tables of AT consumption have been established for different combinations of risk factors.
ACCESSION #
12408540

 

Related Articles

  • Delayed thrombin generation is not associated with fibrinopeptide formation during prolonged cardiopulmonary bypass with hirudin anticoagulation. Belway, D.; Rubens, F. D.; Henley, B.; Babaev, A.; Mesana, T. // Perfusion;Sep2006, Vol. 21 Issue 5, p259 

    Patients with heparin-induced thrombocytopenia urgently requiring surgery with cardiopulmonary bypass (CPB) present a unique management challenge that must be addressed by the use of alternative anticoagulants. Although clinical success with the direct thrombin inhibitor hirudin has been...

  • Promise and challenges of anticoagulation with dabigatran. Verma, Ashish; Chhibber, Vishesh; Emhoff, Timothy; Klinger, Dagmar // Clinical Kidney Journal;Aug2012, Vol. 5 Issue 4, p336 

    Dabigatran, marketed as Pradaxa (Boehringer Ingelheim) in the USA, is a direct thrombin inhibitor that holds great promise. It has been shown to reduce the risk of stroke and venous thromboembolism with similar if not greater efficacy than warfarin and with far fewer side effects. However, like...

  • Indications for cardiopulmonary bypass in non-cardiac operations. Nair, KS; Lawrence, DR; Punjabi, PP; Taylor, KM // Perfusion;May2002, Vol. 17 Issue 3, p161 

    Focuses on the use of cardiopulmonary bypass in non-cardiac surgical operations. Definition of accidental hypothermia; Resuscitation of patients with severe respiratory failure; Single- and double-lung transplantation.

  • You haven't lived until you've died. Flynn, Ramsey; Vadukul, Nitin // Esquire;Dec98, Vol. 130 Issue 6, p95 

    Details the experiences of the author when he was going under a cardiopulmonary bypass. Emotions before and after the operation; Description of the operation.

  • Antithrombin level and circuit thrombosis during hemofiltration after cardiopulmonary bypass. Lanquetot, H.; Leprince, T.; Ragot, S.; Boinot, C.; Jayle, C.; Robert, R.; Macchi, L. // Intensive Care Medicine;Nov2008, Vol. 34 Issue 11, p2068 

    Hemofilter thrombosis occurs frequently during continuous veno-venous hemofiltration in intensive care units. Among coagulation disorders, antithrombin deficiency has been shown to be linked to hemofilter thrombosis. We investigated whether there was an association between antithrombin level...

  • Gabexate mesilate and antithrombin III for intraoperative anticoagulation in heparin pretreated patients. Ranucci, M.; Cazzaniga, A.; Isgrò, G.; Ditta, A.; Boncilli, A.; Cotza, M.; Brozzi, S. // Perfusion;1999, Vol. 14 Issue 5, p357 

    Thirty patients scheduled for elective myocardial revascularization and having undergone preoperative heparin treatment have been admitted to this prospective, randomized study. The aim of the study was to test two different strategies for preserving circulating antithrombin III (AT-III) during...

  • A Novel Antidote-Controlled Anticoagulant Reduces Thrombin Generation and Inflammation and Improves Cardiac Function in Cardiopulmonary Bypass Surgery. Nimjee, Shahid M.; Keys, J. R.; Pitoc, G. A.; Quick, G.; Rusconi, C. P.; Sullenger, Bruce A. // Molecular Therapy;Sep2006, Vol. 14 Issue 3, p408 

    Heparin and protamine are the standard anticoagulant–antidote regimen used in almost every cardiopulmonary bypass (CPB) procedure even though both are associated with an array of complications and toxicities. Here we demonstrate that an anticoagulant aptamer–antidote pair targeting...

  • Alternatives to unfractioned heparin for anticoagulation in cardiopulmonary bypass. von Segesser, L.K.; Mueller, X.; Marty, B.; Horisberger, J.; Corno, A. // Perfusion;Sep2001, Vol. 16 Issue 5, p411 

    Despite the progress made in the development of cardiopulmonary bypass (CPB) equipment, systemic anticoagulation with unfractioned heparin and post-bypass neutralization with protamine are still used in most perfusion procedures. However, there are a number of situations where unfractioned...

  • A combined approach for improving cardiopulmonary bypass in coronary artery surgery: a pilot study. Baufreton, Christophe; de Brux, Jean Louis; Binuani, Patrice; Corbeau, Jean-Jacques; Subayi, Jean Baptiste; Daniel, Jean Claude; Treanor, Patrick // Perfusion;Nov2002, Vol. 17 Issue 6, p407 

    Background: This is a pilot study carried out to assess the feasibility and the clinical impact of a combined approach of cardiopulmonary bypass (CPB) with reduced anti-coagulation. Methods: We used a retrospective, non-randomized analysis of 45 consecutive patients undergoing coronary artery...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics